The cytotoxicity of this family of 2,6-bis(arylimino)pyridine compounds,
with cisplatin as reference compound, was studied in the following
human cancer cell lines: HCT-15 (colon adenocarcinoma), PC-3
(prostate adenocarcinoma), MCF-7 (breast adenocarcinoma) and HeLa
(cervical uterine adenocarcinoma)